Altamira Therapeutics Ltd. Other Finance Income Cost
Altamira Therapeutics Ltd. (CYTOF) reported Other Finance Income Cost of CHF 1.67 million for the 12-month period ending 2023-12-24, per its 20-F/A filed 2024-04-22.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:OtherFinanceIncomeCost · last filed 2024-04-22
| Period end | Other Finance Income Cost 12 month |
|---|---|
| 2023-12-24 | 1.67M CHF 20-F/A · filed 2024-04-22 |
| 2022-12-24 | 1.21M CHF 20-F/A · filed 2024-04-22 |
| 2021-12-24 | 14.11K CHF 20-F/A · filed 2024-04-22 |